Financial results Pursuant to Regulation 30 and 33(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amal Ltd reported strong FY25 results with standalone revenue from operations rising to ₹4,888.11 lakhs from ₹3,133.43 lakhs (~56% YoY growth), and standalone profit after tax jumping to ₹687.52 lakhs from ₹242.63 lakhs (~183% YoY). On a consolidated basis, revenue grew to ₹13,531.72 lakhs from ₹8,609.38 lakhs (~57% YoY), while consolidated PAT surged to ₹2,929.21 lakhs from ₹170.46 lakhs, driven by full-year contribution from subsidiary Amal Speciality Chemicals. Standalone EPS rose to ₹5.56 (from ₹1.96) and consolidated EPS to ₹23.69 (from ₹1.23). The Board recommended a final dividend of 10% (₹1.00 per share), subject to shareholder approval at the AGM on August 29, 2025. Deloitte Haskins & Sells LLP issued an unqualified audit opinion on both standalone and consolidated results. The Board also appointed SPANJ & Associates as Secretarial Auditor for three years (FY26–FY28).
Strong revenue and profit growth, especially at the consolidated level where the subsidiary is now contributing meaningfully, should be viewed positively by shareholders. The modest ₹1 dividend payout (only ~18% of standalone EPS) suggests the company is retaining cash for growth rather than rewarding shareholders generously.